Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.QuantRx Biomedica, a broad-based diagnostics company, has entered into a technology licensing agreement with Church & Dwight Co, a provider of sodium bicarbonate products.
Subscribe to our email newsletter
Under the terms of the agreement, Church & Dwight acquired exclusive world-wide rights to use certain QuantRx technology related to a jointly developed at-home diagnostic test for the consumer over-the-counter market.
Under the long-term agreement, QuantRx has received a commercialization fee and shall receive royalties on net sales of the product.
QuantRx expects that the product will be launched by Church & Dwight under its First Response brand and will be available at the retail level in the second quarter of 2009.
William Fleming, president of diagnostic group at QuantRx, said: “This partnership helps underscore our ability to rapidly apply our technological expertise to meet the market needs of our partners. It also provides QuantRx with a long-term revenue stream, while we continue developing a robust proprietary product pipeline to bring innovative products to the point-of-care market.”